This site is intended for Healthcare professionals only.

Lupin launches generic drug to control postpartum hemorrhage in US


Lupin launches generic drug to control postpartum hemorrhage in US

New Delhi: Drug maker Lupin launched Methylergonovine Maleate tablets, used for prevention and control of postpartum hemorrhage, in the American market.

The company has launched the product in the US after having received approval from the US Food and Drug Administration (USFDA) earlier, Lupin said in a statement.

Lupin’s product is the generic equivalent of Novartis Pharmaceuticals Corp’s Methergine which is indicated for prevention and control of postpartum hemorrhage.

As per the latest industry estimates, Methylergonovine Maleate tablets had annual sales of around USD 71.5 million in the US.



Source: PTI
0 comment(s) on Lupin launches generic drug to control postpartum hemorrhage in US

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted